Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorThe University of Texas Health Science Center, Houston

About this trial

The objective is to test the efficacy of a laparotomy-assisted fetoscopic surgical approach to cover spina bifida spinal cord developmental defects using cryopreserved human umbilical cords (NEOX Cord 1K®) as a meningeal and skin patch.

Eligibility criteria

Qualifiers

Singleton pregnancy

Gestational age at screening is 19 to 25 5/7 weeks and gestational age at surgery is 22 to 25 6/7 weeks

Maternal age: 18 years and older

Body mass index ≤45 kg/m2 (pre-pregnancy)

Disqualifiers

Non-resident of the United States

Multifetal pregnancy

Poorly controlled insulin-dependent pregestational diabetes

Poorly controlled A2 diabetes mellitus (A2DM) insulin-dependent diabetes

Trial design

Treatments tested in this trial

  • NEOX Cord 1K applied fetoscopically

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

The University of Texas Health Science Center, Houston

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator